Cost-Effectiveness of Laporoscopic Surgery


Project Name

Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer





Project Collaborators

Prof. Craig Ramsay ~ HSRU, Aberdeen Univrsity

Prof. Luke Vale ~ IHS, Newcastle University



Project Description


Men diagnosed with localized prostate cancer predominantly choose radical prostatectomy as their preferred curative treatment option with approximately 88,000 procedures carried out in theUnited States of Americain 2008 and 6,000 in theUnited Kingdomin 2010.   Over the last 30 years surgeon and medical technologist innovators have worked to reduce the morbidity of the procedure in terms of minimization of blood loss, preservation of urinary continence and maintenance of existing sexual function whilst ensuring efficacy for cancer control.  This has involved refining the standard technique of open retropubic radical prostatectomy, establishment of laparoscopic prostatectomy, and most recently the introduction of remote surgery.

Previous health technology assessments (HTA) of robotic and laparoscopic prostatectomy have not included cost-effectiveness analysis due to the lack of direct comparative data and are confined to summarizing differences in direct costs  whilst recommending further methodologically robust clinical studies.  This objectives of this project  were to undertake a meta-analysis of data from a systematic review of  published information on the costs and efficiacy of laporoscopic and robotic prostatectomy and to define inputs for an economic evaluation based upon a discrete event simulation comparing the two approaches